0001171843-12-004058.txt : 20121109 0001171843-12-004058.hdr.sgml : 20121109 20121109090035 ACCESSION NUMBER: 0001171843-12-004058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20121109 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20121109 DATE AS OF CHANGE: 20121109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED GUARDIAN INC CENTRAL INDEX KEY: 0000101295 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 111719724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10526 FILM NUMBER: 121191839 BUSINESS ADDRESS: STREET 1: 230 MARCUS BLVD CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: 631-273-0900 MAIL ADDRESS: STREET 1: P.O. BOX 18050 STREET 2: 230 MARCUS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: UNITED INTERNATIONAL RESEARCH INC DATE OF NAME CHANGE: 19820422 8-K 1 document.htm FORM 8-K FILING DOCUMENT Form 8-K Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 9, 2012


United-Guardian, Inc.
(Exact name of registrant as specified in its charter)


Delaware

001-10526

11-1719724
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification No.)


230 Marcus Boulevard, Hauppauge, New York 11788
(Address of principal executive offices)


Registrant's telephone number, including area code: (631) 273-0900


Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

  [   ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  [   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  [   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition.

On November 9, 2012 the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

    Exhibit 99.1.       Press release dated November 9, 2012


SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

United-Guardian, Inc.

Date: November 9, 2012 By:   /s/   KEN GLOBUS
Ken Globus
President




  Exhibit Index
  99.1 Press release dated November 9, 2012






EX-99 2 newsrelease.htm PRESS RELEASE United-Guardian Reports Third Quarter Results

EXHIBIT 99.1

United-Guardian Reports Third Quarter Results

HAUPPAUGE, N.Y., Nov. 9, 2012 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (Nasdaq:UG) today announced financial results for its fiscal 2012 third quarter ended September 30, 2012. The Company reported quarterly revenue of approximately $3,527,000 and quarterly net income of $1,116,000, or $0.24 per share. This compares with revenue of $3,345,000 and net income of $1,369,000 ($0.30 per share) for the same quarter in 2011. For the nine-month period ended September 30, 2012 revenue was up slightly from $11,047,000 to $11,151,000, and earnings decreased by 6% from $3,760,000 ($0.82 per share) to $3,538,000 ($0.77 per share).

"Although our earnings declined as a result of the production problems we are experiencing with our Renacidin® Irrigation, we still had a very profitable quarter, with increased sales of personal care products making up for much of the loss of Renacidin revenue," stated Ken Globus, United's President. "The comparison with the third quarter of last year is also affected by the monetary settlement that took place in last year's third quarter with our Renacidin supplier, which accounted for $0.05 of the earnings per share for that quarter. We hope to recover most, if not all, of the earnings we lost in fiscal 2012 as a result of the current Renacidin production curtailment. On a positive note, net sales for the quarter were up, with sales of personal care products increasing by 12%, and sales of medical products increasing by 14%, over last year's third quarter. We expect those sales to continue to increase as we expand the marketing and development of those two product lines."

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

The United-Guardian, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6000

NOTE: This press release contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company's expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the "safe harbor" provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company's business please refer to the company's reports and filings with the Securities and Exchange Commission.

RESULTS FOR THE THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2012 and SEPTEMBER 30, 2011
(UNAUDITED)
 
  THREE MONTHS ENDED
SEPTEMBER 30,
 NINE MONTHS ENDED 
SEPTEMBER 30,
   2012  2011 2012 2011
         
Net sales $3,527,387 $3,345,035 $11,151,179 $11,047,383
         
Costs and expenses:        
Cost of sales 1,334,491 1,229,561 4,339,450 4,318,444
Operating expenses  598,100  537,248 1,749,217 1,759,177
Total costs and expenses 1,932,591 1,766,809 6,088,667 6,077,621
         
Income from operations 1,594,796 1,578,226 5,062,512 4,969,762
         
Other income:        
Investment income   51,065 61,308  162,413 205,211
Gain on sale of assets  -- 12,267  2,750  18,251
Income from damage settlement  -- 385,182  -- 385,182
Total other income   51,065 458,757  165,163  608,644
         
Income before income taxes 1,645,861 2,036,983 5,227,675 5,578,406
         
Provision for income taxes 529,700  667,700 1,689,800  1,818,300
         
Net Income $1,116,161 $ 1,369,283 $3,537,875 $3,760,106
         
Earnings per common share (Basic and Diluted) $ 0.24 $ 0.30 $ 0.77 $ 0.82
         
Weighted average shares – basic and diluted 4,596,439 4,596,439 4,596,439 4,596,439

Additional financial information can be found at the company's web site at www.u-g.com.

CONTACT: Robert S. Rubinger
         Public Relations
         (631) 273-0900